When gastric emptying is slowed by GLP-1 medications, this gastric distension lasts longer , leading to pressure, bloating, and prolonged fullness
Studies show some patients need a 1025% increase in Synthroid dose when starting GLP-1 therapy
In this letter, Im going to show you what that mistake was, how it reframes the entire conversation around GLP-1-based weight loss drugs, and offer practical insights to minimize functional muscle loss while taking incretin-based weight loss drugs
By providing the structural foundation necessary to rebuild a healthy, butyrate-producing microbiome, supplements like Fiber MGP offer a scientifically validated pathway for breaking the vicious cycle of leaky gut, systemic endotoxemia, and chronic immune hyper-reactivity seen in complex chronic illnesses
This process is what makes semaglutide an effective treatment in helping people with type 2 diabetes, the risk for which is increased by being overweight or obese